AI-generated summary
The authors pooled five randomized controlled trials of photobiomodulation therapy (PBMT) given to prevent radiation dermatitis in breast and head and neck cancer patients. They report that PBMT was associated with less severe dermatitis at the end of radiotherapy and fewer radiotherapy interruptions, though confidence intervals were wide. The authors state that larger studies are needed to confirm these findings.
- Studies included
- 5
- Who or what was studied
- Patients undergoing radiotherapy for breast or head and neck cancer
- Limits stated in the abstract
- The authors note the need for larger sample sizes and studies in other cancer sites, and the results show wide confidence intervals.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Systematic review, Meta-analysis, GRADE, Randomized controlled trial, Control group, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.